13F

Stock

Iovance Biotherapeutics, Inc.

IOVA · held by 2 managers

Reported value

$4.14M

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$25.6K

Price effect on 1 books still in the name

Largest holder

$4.03M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC631K$4.03MHeld
Leonteq Securities AG16.6K$105.8K−$25.6KAdded$29K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.